Briggs W. Morrison
2018
In 2018, Briggs W. Morrison earned a total compensation of $2.1M as Chief Executive Officer at Syndax Pharmaceuticals, a 24% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $247,660 |
---|---|
Option Awards | $1,263,780 |
Salary | $566,073 |
Other | $3,000 |
Total | $2,080,513 |
Morrison received $1.3M in option awards, accounting for 61% of the total pay in 2018.
Morrison also received $247.7K in non-equity incentive plan, $566.1K in salary and $3K in other compensation.
Rankings
In 2018, Briggs W. Morrison's compensation ranked 5,532nd out of 14,244 executives tracked by ExecPay. In other words, Morrison earned more than 61.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,532 | 61st |
Manufacturing | 2,088 | 64th |
Chemicals And Allied Products | 770 | 64th |
Drugs | 644 | 64th |
Pharmaceutical Preparations | 497 | 64th |
Morrison's colleagues
We found two more compensation records of executives who worked with Briggs W. Morrison at Syndax Pharmaceuticals in 2018.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019